Assuntos
Encéfalo/efeitos dos fármacos , Liberação de Histamina/efeitos dos fármacos , Histidina/farmacologia , Falência Hepática Aguda/tratamento farmacológico , Animais , Encéfalo/patologia , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/patologia , Cromatografia Líquida de Alta Pressão , Glutamatos/metabolismo , Hipotálamo/efeitos dos fármacos , Hipotálamo/patologia , Ratos , Ratos Sprague-DawleyAssuntos
Complicações na Gravidez/epidemiologia , Refugiados , Deficiência de Tiamina/epidemiologia , Tiamina/administração & dosagem , Beriberi/epidemiologia , Beriberi/etiologia , Dieta/efeitos adversos , Suplementos Nutricionais , Feminino , Humanos , Lactação/fisiologia , Bem-Estar Materno , Leite Humano/química , Mianmar/epidemiologia , Estado Nutricional , Gravidez , Complicações na Gravidez/tratamento farmacológico , Tailândia/epidemiologia , Tiamina/metabolismo , Deficiência de Tiamina/tratamento farmacológicoRESUMO
Although earlier studies on thiamine deficiency have reported increases in extracellular glutamate concentration in the thalamus, a vulnerable region of the brain in this disorder, the mechanism by which this occurs has remained unresolved. Treatment with pyrithiamine, a central thiamine antagonist, resulted in a 71 and 55% decrease in protein levels of the astrocyte glutamate transporters GLT-1 and GLAST, respectively, by immunoblotting in the medial thalamus of day 14 symptomatic rats at loss of righting reflexes. These changes occurred prior to the onset of convulsions and pannecrosis. Loss of both GLT-1 and GLAST transporter sites was also confirmed in this region of the thalamus at the symptomatic stage using immunohistochemical methods. In contrast, no change in either transporter protein was detected in the non-vulnerable frontal parietal cortex. These effects are selective; protein levels of the astrocyte GABA transporter GAT-3 were unaffected in the medial thalamus. In addition, astrocyte-specific glial fibrillary acidic protein (GFAP) content was unchanged in this brain region, suggesting that astrocytes are spared in this disorder. Loss of GLT-1 or GLAST protein was not observed on day 12 of treatment, indicating that down-regulation of these transporters occurs within 48 h prior to loss of righting reflexes. Finally, GLT-1 content was positively correlated with levels of the neurofilament protein alpha-internexin, suggesting that early neuronal drop-out may contribute to the down-regulation of this glutamate transporter and subsequent pannecrosis. A selective, focal loss of GLT-1 and GLAST transporter proteins provides a rational explanation for the increase in interstitial glutamate levels, and may play a major role in the selective vulnerability of thalamic structures to thiamine deficiency-induced cell death.
Assuntos
Transportadores de Cassetes de Ligação de ATP/metabolismo , Astrócitos/fisiologia , Regulação para Baixo/fisiologia , Ácido Glutâmico/metabolismo , Tálamo/metabolismo , Encefalopatia de Wernicke/metabolismo , Sistema X-AG de Transporte de Aminoácidos , Animais , Antimetabólitos/farmacologia , Transporte Biológico , Proteínas de Transporte/metabolismo , Modelos Animais de Doenças , Humanos , Immunoblotting , Imuno-Histoquímica , Proteínas de Filamentos Intermediários , Masculino , Lobo Parietal/metabolismo , Piritiamina/farmacologia , Ratos , Ratos Sprague-Dawley , Estatística como Assunto , Deficiência de Tiamina/induzido quimicamente , Deficiência de Tiamina/metabolismo , Encefalopatia de Wernicke/induzido quimicamenteRESUMO
There is increasing evidence that central noradrenaline (NA) transport mechanisms are implicated in the central nervous system complications of acute liver failure. In order to assess this possibility, binding sites for the high affinity NA transporter ligand [3H]-nisoxetine were measured by quantitative receptor autoradiography in the brains of rats with acute liver failure resulting from hepatic devascularization and in appropriate controls. In vivo microdialysis was used to measure extracellular brain concentrations of NA. Severe encephalopathy resulted in a significant loss of [3H]-nisoxetine sites in frontal cortex and a concomitant increase in extracellular brain concentrations of NA in rats with acute liver failure. A loss of transporter sites was also observed in thalamus of rats with acute liver failure. This loss of NA transporter sites could result from depletion of central NA stores due to a reserpine-like effect of ammonia which is known to accumulate to millimolar concentrations in brain in ischemic liver failure. Impaired NA transport and the consequent increase in synaptic concentrations and increased stimulation of neuronal and astrocytic noradrenergic receptors could be implicated in the pathogenesis of the encephalopathy and brain edema characteristic of acute liver failure.
Assuntos
Proteínas de Transporte/metabolismo , Lobo Frontal/metabolismo , Encefalopatia Hepática/metabolismo , Isquemia/complicações , Falência Hepática/complicações , Fígado/irrigação sanguínea , Proteínas do Tecido Nervoso/deficiência , Simportadores , Doença Aguda , Amônia/metabolismo , Animais , Edema Encefálico/etiologia , Edema Encefálico/metabolismo , Fluoxetina/análogos & derivados , Fluoxetina/metabolismo , Encefalopatia Hepática/etiologia , Masculino , Proteínas do Tecido Nervoso/metabolismo , Norepinefrina/metabolismo , Proteínas da Membrana Plasmática de Transporte de Norepinefrina , Derivação Portocava Cirúrgica , Ratos , Ratos Sprague-Dawley , Tálamo/metabolismoRESUMO
"Peripheral-type" benzodiazepine receptors (PTBRs) are highly expressed on the outer mitochondrial membrane of several types of glial cells. In order to further elucidate the nature of the early glial cell changes in thiamine deficiency, PTBR sites and PTBR mRNA were measured in thalamus, a brain structure which is particularly vulnerable to thiamine deficiency, of thiamine-deficient rats at presymptomatic and symptomatic stages of deficiency. PTBR sites were measured using an in vitro binding technique and the selective radio ligand [3H]-PK11195. PTBR gene expression was measured by RT-PCR using oligonucleotide primers based upon the published sequence of the cloned rat PTBR. Microglial and astrocytic changes in thalamus due to thiamine deficiency were assessed using immunohistochemistry and antibodies to specific microglial (ED-1) and astrocytic (GFAP) proteins respectively. Significant increases of [3H]-PK11195 binding sites and concomitantly increased PTBR mRNA were observed in thalamus at the symptomatic stage of thiamine deficiency, coincident with severe neuronal cell loss and increased GFAP-immunolabelling (indicative of reactive gliosis). Positron Emission Tomography using 11C-PK11195 could provide a novel approach to the diagnosis and assessment of the extent of thalamic damage due to thiamine deficiency in humans with Wernicke's Encephalopathy.
Assuntos
RNA Mensageiro/metabolismo , Receptores de GABA-A/metabolismo , Tálamo/metabolismo , Deficiência de Tiamina/metabolismo , Animais , Sequência de Bases , Primers do DNA , Proteína Glial Fibrilar Ácida/metabolismo , Isoquinolinas/metabolismo , Masculino , RNA Mensageiro/genética , Ratos , Ratos Sprague-Dawley , Receptores de GABA-A/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Deficiência de Tiamina/genética , TrítioRESUMO
These is increasing evidence to suggest that central noradrenergic mechanisms may contribute to the central nervous system manifestations of acute liver failure. To further elucidate this possibility, extracellular brain concentrations of the monoamines, noradrenaline (NA), dopamine (DA), and serotonin, were measured by high-performance liquid chromatography with electrochemical detection in microdialysates from the extracellular compartment of frontal cortex in rats with acute (ischemic) liver failure at various times during the progression of encephalopathy and brain edema, as well as in obligate control groups of animals. In addition, binding sites for the noradrenergic receptor subtype ligands, [3H]-prazosin (alpha1 sites), [3H]-RX821002 (alpha2 sites), and [125]I-iodopindolol (beta sites), were assessed using quantitative receptor autoradiography in regions of the brains of rats at coma stage of acute liver failure and of control groups of animals. Coma stages of encephalopathy in acute liver failure were associated with selectively increased noradrenaline concentrations (P < .05) and a concomitant selective loss of alpha1 and beta1 sites in frontal cortex and thalamus. These findings add to a growing body of evidence that central noradrenergic function is modified in acute liver failure and suggest that alpha1/beta1 receptor-mediated noradrenergic mechanisms may play a role in the pathogenesis of brain edema and encephalopathy in this condition.
Assuntos
Córtex Cerebral/metabolismo , Lobo Frontal/metabolismo , Falência Hepática Aguda/metabolismo , Norepinefrina/metabolismo , Antagonistas Adrenérgicos alfa/metabolismo , Antagonistas Adrenérgicos alfa/farmacologia , Antagonistas Adrenérgicos beta/metabolismo , Antagonistas Adrenérgicos beta/farmacologia , Animais , Autorradiografia , Cromatografia Líquida de Alta Pressão , Coma/metabolismo , Dopamina/metabolismo , Hipocampo/química , Hipotálamo/química , Idazoxano/análogos & derivados , Idazoxano/metabolismo , Microdiálise , Pindolol/análogos & derivados , Pindolol/metabolismo , Prazosina/metabolismo , Propanolaminas/farmacologia , Putamen/química , Ratos , Ratos Sprague-Dawley , Receptores Adrenérgicos/análise , Serotonina/metabolismo , Tálamo/químicaRESUMO
The relationship between progression of neurological status and the activities of both Na+,K(+)- and Mg(2+)-dependent-ATPase (adenosine 5'-triphosphate phosphohydrolase) was investigated in brain regions of pyrithiamine-induced thiamine deficient rats. Thalamic Na+,K(+)-ATPase activity was selectively increased by 200% (P < 0.01) prior to the appearance of symptoms of thiamine deficiency and normalized in symptomatic rats. This selective transitory activation precludes a mediation by brain soluble fraction Na+,K(+)-ATPase modifiers as does the unaltered distribution in regional high-affinity [3H]ouabain binding densities observed throughout the time-course used in these experiments. Na+,K(+)-ATPase maintains cellular ionic gradients and has been implicated in neurotransmitter uptake and release mechanisms. The fact that the increased thalamic Na+,K(+)-ATPase activity coincides with the early alterations in serotonin metabolism observed in similarly treated animals and the concomitantly early increase in glucose utilization previously observed in the thalamus of thiamine-deficient rats is discussed.
Assuntos
ATPase Trocadora de Sódio-Potássio/metabolismo , Tálamo/enzimologia , Deficiência de Tiamina/enzimologia , Animais , Cerebelo/enzimologia , Inibidores Enzimáticos/metabolismo , Antagonistas do Ácido Fólico , Masculino , Ouabaína/metabolismo , Pirimetamina , Ratos , Ratos Sprague-Dawley , Deficiência de Tiamina/induzido quimicamenteRESUMO
Portal-systemic encephalopathy (PSE) is characterized by neuropsychiatric symptoms progressing through stupor and coma. Previous studies in human autopsy tissue and in experimental animal models of PSE suggest that alterations in levels of brain amino acids may play a role in the pathogenesis of PSE. To assess this possibility, levels of amino acids were measured using in vivo cerebral microdialysis in frontal cortex of portacaval-shunted rats administered ammonium acetate (3.85 mmol/kg, i.p.) to precipitate severe PSE. Sham-operated rats served as controls. Portacaval shunting resulted in significant increases of levels of extracellular glutamine (threefold, p < 0.001), alanine (38%, p < 0.01), aspartate (44%, p < 0.05), phenylalanine (170%, p < 0.001), tyrosine (140%, p < 0.001), tryptophan (63%, p < 0.001), leucine (75%, p < 0.001), and serine (60%, p < 0.001). Administration of ammonium acetate to sham-operated animals led to a significant increase in extracellular glutamine and taurine content, but this response was absent in shunted rats. The lack of taurine release into extracellular fluid following ammonium acetate administration in portacaval-shunted rats could relate to the phenomenon of brain edema in these animals. Ammonium acetate administration resulted in significant increases in the extracellular concentrations of phenylalanine and tyrosine in both sham-operated and portacaval-shunted rats. Severe PSE was not accompanied by significant increases in extracellular fluid concentrations of glutamate, aspartate, GABA, tryptophan, leucine, or serine, suggesting that increased spontaneous release of these amino acids in cerebral cortex is not implicated in the pathogenesis of hepatic coma.
Assuntos
Aminoácidos/metabolismo , Encéfalo/metabolismo , Espaço Extracelular/metabolismo , Encefalopatia Hepática/metabolismo , Acetatos/farmacologia , Alanina/metabolismo , Animais , Diálise , Lobo Frontal/metabolismo , Glutamina/metabolismo , Cinética , Masculino , Fenilalanina/metabolismo , Derivação Portocava Cirúrgica , Ratos , Ratos Sprague-Dawley , Taurina/metabolismoRESUMO
The sparse-fur (spf) mutant mouse has an X-linked deficiency of hepatic ornithine transcarbamylase (OTC) and develops hyperammonemia in the postnatal period similar to that seen in human patients. We studied the effect of congenital hyperammonemia on the development of cerebral cholinergic parameters such as choline acetyltransferase (ChAT), acetylcholinesterase (AChE) and high-affinity choline uptake (HACU) in spf mice. The serum ammonia levels of spf mutant mice were significantly elevated after weaning compared with control animals. ChAT activity levels started decreasing in mutant spf mice from the age of 30 days (i.e., immediately after weaning); it reached significantly lower levels in the adult animals. HACU was consistently lower (P < .01) in spf/Y mice compared with controls up to the adult stage. However, there were no marked changes in the activity of AChE between control and hyperammonemic spf mice. The levels of beta-NGF, which is essential for cholinergic differentiation and function, were significantly lower in different brain regions of adult mutant mice compared with normal controls. A treatment of spf/spf breeding females with acetyl-L-carnitine, at a dose of 1.5 mM in drinking water, starting from day 1 of conception, resulted in a significant restoration of ChAT activity levels in some brain regions of the spf/Y offspring. The beta-NGF levels were also significantly elevated after supplementation with ALCAR in mutant mice compared with untreated mutant mice. These data are suggestive of a neurotrophic property of ALCAR during cholinergic deficiency caused by congenital hyperammonemia.
Assuntos
Acetilcarnitina/farmacologia , Acetilcolinesterase/metabolismo , Amônia/sangue , Colina O-Acetiltransferase/metabolismo , Colina/metabolismo , Erros Inatos do Metabolismo/metabolismo , Animais , Encéfalo/enzimologia , Encéfalo/crescimento & desenvolvimento , Encéfalo/metabolismo , Carnitina/sangue , Carnitina/metabolismo , Feminino , Masculino , Camundongos , Camundongos Mutantes , Fatores de Crescimento Neural/metabolismo , Gravidez , Sinaptossomos/metabolismoRESUMO
Thiamine phosphate esters (thiamine monophosphate-TMP; thiamine diphosphate-TDP and thiamine triphosphate-TTP) were measured as their thiochrome derivatives by High Performance Liquid Chromatography in the brains of pyrithiamine-treated rats at various stages during the development of thiamine deficiency encephalopathy. Severe encephalopathy was accompanied by significant reductions of all three thiamine phosphate esters in brain. Neurological symptoms of thiamine deficiency appeared when brain levels of TMP and TDP fell below 15% of normal values. Activities of the TDP-dependent enzyme alpha-ketoglutarate dehydrogenase were more severely reduced in thalamus compared to cerebral cortex, a less vulnerable brain structure. On the other hand, reductions of TTP, the non-cofactor form of thiamine, occurred to a greater extent in cerebral cortex than thalamus. Early reductions of TDP-dependent enzymes and the ensuing metabolic pertubations such as lactic acidosis impaired brain energy metabolism, and NMDA-receptor mediated excitotoxicity offer rational explanations for the selective vulnerability of brain structures such as thalamus to the deleterious effects of thiamine deficiency.
Assuntos
Deficiência de Tiamina/metabolismo , Tiamina Monofosfato/metabolismo , Tiamina Pirofosfato/metabolismo , Tiamina Trifosfato/metabolismo , Encefalopatia de Wernicke/metabolismo , Animais , Córtex Cerebral/metabolismo , Masculino , Ratos , Ratos Sprague-Dawley , Tálamo/metabolismo , Encefalopatia de Wernicke/enzimologiaRESUMO
Activities of choline acetyltransferase, acetylcholinesterase and butyrylcholinesterase were studied in the frontal cortex, temporal cortex, cerebellum and caudate nucleus obtained at autopsy from eight alcoholic cirrhotic patients who died in hepatic coma and from an equal number of age-matched subjects free from hepatic, neurological or psychiatric disorders. Activities of these enzymes were unaltered in the brains of cirrhotics compared to controls. Choline acetyltransferase and cholinesterase activities were also studied in the cerebral cortex, cerebellum, brain stem and striatum of rats four weeks following portacaval anastomosis and their sham-operated controls. Portacaval-shunting did not cause any statistically significant differences in the activities of choline acetyltransferase, acetyl or butyrylcholinesterases. These results argue against a presynaptic cholinergic lesion in human and experimental portal-systemic encephalopathy.
Assuntos
Acetilcolinesterase/metabolismo , Encéfalo/enzimologia , Colina O-Acetiltransferase/metabolismo , Encefalopatia Hepática/enzimologia , Idoso , Animais , Núcleo Caudado/metabolismo , Cerebelo/metabolismo , Lobo Frontal/metabolismo , Humanos , Cirrose Hepática Alcoólica/enzimologia , Cirrose Hepática Alcoólica/metabolismo , Masculino , Pessoa de Meia-Idade , Derivação Portocava Cirúrgica , Ratos , Ratos Sprague-Dawley , Lobo Temporal/metabolismoRESUMO
The kinetics and distribution of [3H]tryptamine binding sites in human brain were investigated. Specific [3H]tryptamine binding in frontal cortex was of nanomolar affinity, reversible, saturable, and best fit to a single-site model. A heterogeneous distribution for this binding site was demonstrated, with the highest density observed in hippocampus, thalamus >> caudate nucleus, frontal cortex, pons, temporal cortex > globus pallidus/putamen, cerebellum. The similarities in kinetics and distribution of the [3H]tryptamine binding site in human and rat brain indicate that these two binding sites represent homologous structures. However, the present displacement studies using various ligands (indoleamines and other tryptophan metabolites, phenylethylamines, and miscellaneous drugs) and salts (Na+, K+, Ca2+, Mg2+, Cu2+) indicate stereospecific displacement as well as a rank-order potency profile that is different from that reported for the rat [3H]tryptamine binding site. This suggests the presence of distinct species-dependent [3H]tryptamine binding site subtypes. Taken together with the documented electrophysiological and behavioral evidence of tryptamine-mediated effects in the rat and the recent report of a significant loss of these binding sites in human portal systemic encephalopathy, as well as the present demonstration of an effect of guanine nucleotides on [3H]-tryptamine binding affinity, these findings suggest that these binding sites might be functional receptors. The implied role of tryptamine in neuropsychiatric disorders is supported by this demonstration of a receptor for [3H]-tryptamine in human brain.
Assuntos
Encéfalo/metabolismo , Receptores de Serotonina/metabolismo , Triptaminas/metabolismo , Animais , Lobo Frontal/efeitos dos fármacos , Lobo Frontal/metabolismo , Guanilil Imidodifosfato/farmacologia , Hipocampo/metabolismo , Humanos , Cinética , Ratos , Receptores de Serotonina/efeitos dos fármacos , Sulfatos/farmacologia , Tálamo/metabolismo , Distribuição Tecidual , TrítioRESUMO
Thiamine diphosphatase (TDPase) activity was measured using a colorimetric assay in frontal and temporal cortex obtained at autopsy from eight patients with neuropathologically confirmed Alzheimer's disease (AD) and from an equal number of control patients matched for age and autopsy delay interval, free from neurological or psychiatric disorders. TDPase activities were significantly reduced in frontal cortex (by 28%, P < 0.05) and temporal cortex (by 62%, P < 0.01) of AD patients. These findings add to a growing body of evidence of altered thiamine neurochemistry in AD. Given the previous reports of an association of TDPase with cholinergic nerve terminals, loss of TDPase activities could reflect loss of cholinergic neurons in frontal and temporal cortex in AD.
Assuntos
Hidrolases Anidrido Ácido/metabolismo , Doença de Alzheimer/enzimologia , Lobo Frontal/enzimologia , Lobo Temporal/enzimologia , Idoso , Colorimetria , Feminino , Histocitoquímica , Humanos , Masculino , Sistema Nervoso Parassimpático/enzimologia , Sistema Nervoso Parassimpático/patologiaRESUMO
Spontaneous animal models of inborn errors of metabolism are valuable tools for defining the pathogenesis of these disorders and also the mechanism of various therapeutic approaches. In the present study, we have employed BALB/cByJ mice with an autosomal recessive deficiency of short-chain acyl-CoA dehydrogenase (SCAD). These animals were characterized by a marked urinary excretion of ethylmalonic and methylsuccinic acids along with butyrylglycine. Using adult homozygous mice we have studied the basic cerebral and hepatic profile of carnitine, ammonia, and energy metabolism. The effects of fasting and a short-term supplement of L-carnitine have been evaluated in comparison with control BALB/cJ mice. The mutant mice had low levels of acetyl-CoA and high levels of lactate compared to control mice. Fasting aggravated this condition by further decreasing acetyl-CoA and increasing lactate levels in the mutant mice. Free carnitine levels were significantly decreased in liver with fasting. Long-chain acylcarnitines were significantly lower in the brain of mutant mice. A short-term supplementation of L-carnitine resulted in general increases of carnitine levels in liver and muscle, but they still remained lower in mutant BALB/cByJ mice as compared to control BALB/cJ mice. L-Carnitine treatment increased cerebral CoA-SH levels and both hepatic and cerebral acetyl-CoA levels in mutant mice. Hyperammonemia which has been described frequently in acyl-CoA dehydrogenase deficiencies was not observed in adult BALB/cByJ mice. This could be due to a rapid conjugation of butyryl-CoA with glycine by an increased activity of glycine N-acyltransferase.
Assuntos
Acidose/metabolismo , Acil-CoA Desidrogenase de Cadeia Longa/deficiência , Amônia/metabolismo , Química Encefálica/fisiologia , Carnitina/metabolismo , Metabolismo Energético/fisiologia , Fígado/metabolismo , Acidose/urina , Aciltransferases/metabolismo , Animais , Jejum/metabolismo , Feminino , Masculino , Camundongos , Camundongos Endogâmicos BALB C , FenótipoRESUMO
Microdialysis in the awake, freely moving rat was used to determine the effect of pyrithiamine-induced thiamine deficiency on the levels of amino acids in the brain. Studies were carried out on (a) presymptomatic animals immediately before the development of behavioral changes and (b) acute symptomatic animals within 6 h following loss of righting reflexes. This latter stage precedes the appearance of histological lesions. The results were compared with pair-fed controls. Dialysis probes were implanted in one vulnerable structure [ventral posterior medial thalamus (VPMT)] and one nonvulnerable area [frontal parietal cortex (FPC)] on the contralateral side. In VPMT of acute symptomatic animals, the glutamate concentration was significantly increased (3.37 +/- 0.64 microM; p < 0.005) compared with control values (0.93 +/- 0.09 microM), whereas in FPC no change in glutamate content was evident. These results suggest that glutamate plays a significant role in the development of central thiamine deficiency lesions. The absence of any increase in glutamate levels in the nonvulnerable FPC suggests that a glutamate-mediated excitotoxic mechanism may be responsible for the selective cerebral vulnerability in thiamine deficiency.
Assuntos
Encéfalo/metabolismo , Espaço Extracelular/metabolismo , Glutamatos/metabolismo , Deficiência de Tiamina/metabolismo , Aminoácidos/metabolismo , Animais , Diálise , Ácido Glutâmico , Masculino , Concentração Osmolar , Lobo Parietal/metabolismo , Ratos , Ratos Sprague-Dawley , Tálamo/metabolismoRESUMO
Sparse-fur (spf) mutant mice with X-linked ornithine transcarbamylase deficiency were used to study the effect of L-carnitine on energy metabolites in congenital hyperammonemia. L-Carnitine was used at doses of 2, 4, 8, or 16 mmol/kg body weight (BW), and levels of ammonia, glutamine, glutamate, and some intermediates of energy metabolism were measured in brain and liver of spf/Y mice. Cerebral and hepatic levels of ammonia were decreased with 4 mmol L-carnitine (P < .001), whereas other doses did not seem to have any effect on this metabolite. Cerebral levels of glutamine were decreased following administration of L-carnitine at doses of up to 4 mmol/kg BW, whereas hepatic glutamine levels remained unaltered at all doses of L-carnitine. Both cerebral and hepatic levels of pyruvate, lactate, and alpha-ketoglutarate were decreased at doses of up to 8 mmol L-carnitine/kg BW. L-Carnitine treatment elevated adenosine triphosphate (ATP), free coenzyme A (CoA), and acetyl CoA levels in both brain and liver of spf/Y mice. Cytosolic and mitochondrial redox ratios of spf/Y mice, which were altered by congenital chronic hyperammonemia, were partially corrected by L-carnitine administration. L-Carnitine supplementation to spf/Y mice during sodium benzoate therapy also restored the availability of free CoA and ATP, thus counteracting the adverse effects of higher doses of sodium benzoate. These changes in free CoA and acetyl CoA levels could be due to the deinhibition of pantothenate kinase and stimulation of fatty acid oxidation by L-carnitine.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Amônia/sangue , Benzoatos/uso terapêutico , Encéfalo/metabolismo , Carnitina/farmacologia , Metabolismo Energético/fisiologia , Glutamatos/metabolismo , Glutamina/metabolismo , Doenças do Cabelo/genética , Fígado/metabolismo , Trifosfato de Adenosina/análise , Trifosfato de Adenosina/metabolismo , Erros Inatos do Metabolismo dos Aminoácidos/sangue , Erros Inatos do Metabolismo dos Aminoácidos/metabolismo , Erros Inatos do Metabolismo dos Aminoácidos/fisiopatologia , Amônia/análise , Amônia/metabolismo , Animais , Ácido Benzoico , Peso Corporal/fisiologia , Encéfalo/enzimologia , Química Encefálica , Carnitina/fisiologia , Coenzima A/análise , Coenzima A/metabolismo , Relação Dose-Resposta a Droga , Ligação Genética , Glutamatos/análise , Ácido Glutâmico , Glutamina/análise , Ácidos Cetoglutáricos/análise , Ácidos Cetoglutáricos/metabolismo , Lactatos/análise , Lactatos/metabolismo , Fígado/química , Fígado/enzimologia , Masculino , Camundongos , Camundongos Mutantes , Ornitina Carbamoiltransferase/análise , Ornitina Carbamoiltransferase/fisiologia , Piruvatos/análise , Piruvatos/metabolismo , Fatores de Tempo , Ureia/metabolismoRESUMO
Several neuropathological reports in the last 5 years have described brain lesions characteristic of Wernicke's Encephalopathy in patients with AIDS. Using the erythrocyte transketolase activation assay, we now report biochemical evidence of thiamine deficiency in 9/39 (23%) of patients with AIDS or AIDS-related complex. In no cases was there history of alcohol abuse nor were there clinical signs of Wernicke's Encephalopathy. Thiamine deficiency in these patients most likely results from the cachexia and catabolic state characteristic of AIDS. In view of (i) the confirmed neuropathological evidence of Wernicke's Encephalopathy in AIDS patients, (ii) the significant thiamine deficiency in these patients and (iii) the difficulties of clinical diagnosis of Wernicke's Encephalopathy, it is recommended that dietary thiamine supplementation be initiated in all newly diagnosed cases of AIDS or AIDS-related complex.
Assuntos
Síndrome da Imunodeficiência Adquirida/complicações , Deficiência de Tiamina/complicações , Encefalopatia de Wernicke/complicações , Complexo Relacionado com a AIDS/sangue , Complexo Relacionado com a AIDS/complicações , Complexo Relacionado com a AIDS/enzimologia , Síndrome da Imunodeficiência Adquirida/sangue , Síndrome da Imunodeficiência Adquirida/enzimologia , Adulto , Idoso , Animais , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/enzimologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Ratos , Ratos Endogâmicos , Tiamina/sangue , Deficiência de Tiamina/enzimologia , Transcetolase/metabolismo , Encefalopatia de Wernicke/enzimologia , Zidovudina/farmacologiaRESUMO
Much evidence has accumulated to suggest that the peripheral type benzodiazepine (PBZ) binding site has a predominantly glial localization. Elevated PBZ binding densities have been reported in various models of brain damage, apparently reflecting glial proliferation in response to neurodegeneration. In the present study, PBZ receptor densities were examined in frontal and temporal cortex of Alzheimer's disease (AD) patients using the ligand [3H]PK 11195. There was a highly significant (p less than 0.01) increase in PBZ binding sites in the temporal cortex from AD patients. In the frontal cortex, a moderate increase was observed that approached statistical significance (p = 0.07). Decreased choline acetyltransferase activity was observed in both regions. These findings offer support for the potential use of the PBZ binding site as a marker for gliosis associated with neuronal cell death.
Assuntos
Doença de Alzheimer/metabolismo , Córtex Cerebral/metabolismo , Receptores de GABA-A/metabolismo , Idoso , Idoso de 80 Anos ou mais , Colina O-Acetiltransferase/metabolismo , Feminino , Lobo Frontal/metabolismo , Humanos , Isoquinolinas/farmacologia , Cinética , Masculino , Pessoa de Meia-Idade , Neuroglia/efeitos dos fármacos , Neuroglia/metabolismo , Lobo Temporal/metabolismoRESUMO
Excitatory amino acids have been implicated in the pathogenesis of hepatic encephalopathy. In the present study, kainate, quisqualate and N-methyl-D-aspartate (NMDA) subclasses of L-glutamate receptors were measured in adult rat brain by quantitative receptor autoradiography following surgical construction of an end-to-side portacaval anastomosis (PCA). PCA resulted in sustained hyperammonemia and decreased binding of L-glutamate to the NMDA receptor when compared to sham-operated controls. Decreases in binding ranged from 17 to 39% in several regions of cerebral cortex, hippocampus, striatum, and thalamus. Binding to quisqualate and kainate receptor subtypes was not altered. PCA leads to astrocytic changes in brain but does not result in any measurable loss of neuronal integrity. It is therefore proposed that decreased glutamate binding to the NMDA receptor following PCA results from increased extracellular glutamate caused by decreased reuptake into perineuronal astrocytes and a compensatory down-regulation of these receptors. Such changes could be of pathophysiological significance in hepatic encephalopathy.
Assuntos
Ácido Aspártico/análogos & derivados , Encéfalo/metabolismo , Glutamatos/metabolismo , Derivação Portocava Cirúrgica , Receptores de Neurotransmissores/metabolismo , Amônia/sangue , Animais , Ácido Aspártico/farmacologia , Encéfalo/efeitos dos fármacos , Córtex Cerebral/metabolismo , Corpo Estriado/metabolismo , Regulação para Baixo , Ácido Glutâmico , Hipocampo/metabolismo , Ácido Ibotênico/análogos & derivados , Ácido Ibotênico/metabolismo , Ácido Caínico/metabolismo , Fígado/anatomia & histologia , Masculino , N-Metilaspartato , Tamanho do Órgão , Ratos , Ratos Endogâmicos , Receptores de N-Metil-D-Aspartato , Receptores de Neurotransmissores/efeitos dos fármacos , Tálamo/metabolismo , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol PropiônicoRESUMO
Mammalian brain contains two types of benzodiazepine receptors namely the "central-type" receptor which forme part of the GABA-benzodiazepine receptor complex, and the so-called "peripheral-type" receptor found predominantly on mitocondrial membranes of astrocytes. Brain GABA-related benzodiazepine receptors are unchanged in hepatic encephalopathy. On the other hand, human and experimental hepatic encephalopathy are associated with increased densities of "peripheral type" benzodiazepine receptor. Results of several studies using agonists and antagonists of both types of benzodiazepine receptors are discussed in this review.